Microbix Reports Results for Q4 Full-Year Fiscal 2023 - Yahoo Finance
| MBX Stock | CAD 0.31 0.01 3.13% |
About 62% of Microbix Biosystems' investor base is looking to short. The analysis of the overall investor sentiment regarding Microbix Biosystems suggests that many traders are alarmed. Microbix Biosystems' investing sentiment overview a quick insight into current market opportunities from investing in Microbix Biosystems. Many technical investors use Microbix Biosystems stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Microbix |
Microbix Reports Results for Q4 Full-Year Fiscal 2023 Yahoo Finance
Read at news.google.com
 |
Microbix Biosystems Fundamental Analysis
We analyze Microbix Biosystems' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbix Biosystems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbix Biosystems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Microbix Biosystems is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Microbix Biosystems Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Microbix Biosystems stock to make a market-neutral strategy. Peer analysis of Microbix Biosystems could also be used in its relative valuation, which is a method of valuing Microbix Biosystems by comparing valuation metrics with similar companies.
Peers
Microbix Biosystems Related Equities
| EDT | Spectral Med | 5.66 | ||||
| HBP | Helix BioPharma | 4.82 | ||||
| TH | Theratechnologies | 1.19 | ||||
| ONC | Oncolytics Biotech | 4.35 |
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.